Drug repositioning is a promising strategy to discover new therapeutic applications for existing drugs, significantly reducing the time and costs associated with traditional drug development. This study employs a network medicine approach to analyze successful cases of drug repositioning, focusing on the exploratory hypothesis that the efficacy of repositioning may be determined by functional similarity between between diseases for which the drug was originally designed and diseases for which the same drug is reused. Network medicine tools were employed to investigate the connections between disease-associated genes, proteins, and approved drugs. Biological networks, including protein-protein interactions and functional interactions networks, as well as gene- and drug-disease association data are analyzed to identify functional similarities and possible molecular connections between diseases and treatments. Using clustering techniques and topological analysis, the results reveal a suggestive overlap of involved genes and functional interactions, emphasizing the value of computational methods in accelerating drug repositioning efforts and improving understanding of drug repositioning dynamics for more efficient therapeutic interventions.
Exploring Drug Repurposing Success Stories Through a Network-based Approach: Insights from a Case Study / Pierini, E.; Mazza, L.; Petti, M.; Tieri, P.. - (2024), pp. 6959-6964. (Intervento presentato al convegno 2024 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2024 tenutosi a Lisbon; Portugal) [10.1109/BIBM62325.2024.10822355].
Exploring Drug Repurposing Success Stories Through a Network-based Approach: Insights from a Case Study
Petti M.
;Tieri P.
2024
Abstract
Drug repositioning is a promising strategy to discover new therapeutic applications for existing drugs, significantly reducing the time and costs associated with traditional drug development. This study employs a network medicine approach to analyze successful cases of drug repositioning, focusing on the exploratory hypothesis that the efficacy of repositioning may be determined by functional similarity between between diseases for which the drug was originally designed and diseases for which the same drug is reused. Network medicine tools were employed to investigate the connections between disease-associated genes, proteins, and approved drugs. Biological networks, including protein-protein interactions and functional interactions networks, as well as gene- and drug-disease association data are analyzed to identify functional similarities and possible molecular connections between diseases and treatments. Using clustering techniques and topological analysis, the results reveal a suggestive overlap of involved genes and functional interactions, emphasizing the value of computational methods in accelerating drug repositioning efforts and improving understanding of drug repositioning dynamics for more efficient therapeutic interventions.File | Dimensione | Formato | |
---|---|---|---|
Pierini_Exploring-Drug_2024.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
398.89 kB
Formato
Adobe PDF
|
398.89 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.